The Efficacy and Safety of Fluzopril Combined With Apatinib in Maintenance Treatment of Platinum Resistant Recurrent Ovarian Cancer Patients

NCT06102707 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer Recurrent

Interventions

DRUG: Fluzopril Combined With Apatinib

Sponsor

Qilu Hospital of Shandong University